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MicroRNAs (miRNAs) are an emerging class of non-coding endogenous RNAs involved in multiple cellular processes, including cell 
differentiation. Treatment with Retinoic Acid (RA) results in neural differentiation of neuroblastoma cells. We wanted to elucidate 
whether miRNAs contribute to the gene expression changes induced by RA in neuroblastoma cells, and whether miRNA regulation 
is involved in the transduction of the RA signal. We show here that RA treatment of SH-SY5Y neuroblastoma cells results in 
profound changes in the expression pattern of miRNAs. Up to 42 different miRNA species significantly changed their expression (26 
upregulated and 16 downregulated). Among them, the closely related miR-10a and -10b showed the most prominent expression 
changes. Induction of miR-10a and -10b by RA also could be detected in LA-N-1 neuroblastoma cells. Loss of function experiments 
demonstrated that miR-10a and -10b are essential mediators of RA-induced neuroblastoma differentiation and of the associated 
changes in migration, invasion, and in vivo metastasis. In addition, we found that the SR-family splicing factor SFRS1 (SF2/ASF) is a 
target for miR-10a -and -10b in HeLa and SH-SY5Y neuroblastoma cells. We show here that changes in miR-10a and -10b expression 
levels may regulate SFRS1-dependent alternative splicing and translational functions. Taken together, our results give support to 
the idea that miRNA regulation plays a key role in RA-induced neuroblastoma cell differentiation. The discovery of SFRS1 as direct 
target of miR-10a and -10b support the emerging functional interaction between two post-transcriptional mechanisms, microRNAs 
and splicing, in the neuronal differentiation context. 
1. miRNA expression profiling during RA-induced differentiation 
of neuroblastoma SH-SY5Y cells.  
A.Summary of TaqMan microRNA LDA expression 
profiling results. From 667 miRNAs analyzed, 452 
were detected. Among them  26 were upregulated 
and 16 downregulated by RA treatment. 
 
B and C. Relative expression values detected in 
TaqMan microRNA LDA for microRNAs with 
FDR<0.05, for upregulated (B) and downregulated 
miRNAs (C). The values for 24 (empty bars), 48 
(grey bars) and 96 (black bars) h of RA treatment 
are represented.  
 
D and E. RT-qPCR validation experiments for 
selected upregulated (D) and downregulated (E) 
microRNAs. Data were normalized for the 
expression of U6 small nuclear RNA and the 
relative expression level to the value of 0 h of RA 
treatment represented (mean ± SD from the two 
independent determinations). The values for 0 
(empty bars), 24 (light grey bars), 48 (dark grey 
bars) and 96 (black bars) h of RA treatment are 
shown.  
 
F and G. Expression levels of miR-10a (F) and -10b 
(G) during RA treatment of  SH-SY5Y and LA-N-1 
neuroblastoma cells. The cells were treated with 
RA for the times indicated in the Figure and the 
levels of miR-10a and -10b analyzed by RT-qPCR 
as indicated for Fig. 1 D and E. The graph shows 
the mean ± SD from two independent 
determinations. Black bars: SH-SY5Y cells. Grey 
bars: LA-N-1 cells.  
2. Suppression of miR-10a and -10b endogenous expression results 
in impairment of RA-induced differentiation. 
3. Knockdown of miR-10a and -10b impaired the RA-induced 
reduction of migratory and metastatic abilities of neuroblastoma 
SH-SY5Y cells. 
4. Identification and validation of  splicing regulatory factor SFRS-1 
(SF2/ASF) as direct target of miR-10a and -10b in neuroblastoma cells. 
5. Experimental alteration of miR-10a and -10b expression levels 
impaired the functions of SFRS1 in the regulation of alternative 
splicing and specific mRNA translation . 
A. Migration. Mock-transfected cells and cells transfected with 
Negative Control (NC) anti-miR, anti-miR-10a or anti-miR-10b were 
treated with RA or vehicle for 96 h. Cells from the different 
treatment groups were labeled with Calcein AM and migration 
transwell assays were set with Fluoroblock light-opaque inserts. 
The graph shows a representative experiment performed in 
triplicate (mean ± SD). 
  
B. Invasion. Mock-transfected cells and cells transfected with 
Negative Control (NC) anti-miR, anti-miR-10a or anti-miR-10b were 
treated with RA or vehicle for 96 h. Cells from the different 
treatment groups were used to set transwell Matrigel invasion 
assays. The graph shows the average of three experiments 
performed in triplicate (mean ± SD).  
 
C. Metastasis. Cells transfected with Negative Control (NC) anti-miR 
or anti-miR-10a were treated with RA or vehicle for 96 h. Cells from 
the different treatment groups were transferred to the upper 
chorion-allantoic-membrane of 10-day-old chicken embryos and the 
number of metastatized cells into the lungs evaluated 7 d later. The 
graph represents the values obtained from six parallel assays 
(mean ± SD).  
A-E. Morphological differentiation induced by RA was impaired after 
experimental reduction of miRNA-10a and -10b levels.  
F. RT-qPCR analysis of miRNA-10a and -10b expression levels after 
transfection of SH-SY5Y cells with anti-miR-10a, -10b and negative control 
(NC) anti-miR and subsequent RA treatment for 96 h. For comparison, the 
values obtained with mock-transfected cells treated with vehicle (mock) or 
RA (mock+RA) were shown.  
G. miR-10a or -10b knockdown results in reduced RA-induced neurite 
outgrowth. Quantification of neurite length was performed with Neuron J 
software on photomicrographs obtained after transfection of SH-SY5Y 
cells with anti-miR-10a, -10b and negative control (NC) anti-miR and 
subsequent RA treatment for 96 h. The graph represent the values (mean ± 
SEM) obtained from at least 100 cells for each condition.  
H and I. Suppression of miR-10a and -10b expression did not affected the 
proliferation arrest induced by RA. G. [3H]-Thymidine incorporation in 
control mock-transfected SH-SY5Y neuroblastoma cells and after RA 
treatment for 96 h of mock-transfected cells, or cell transfected with NC-
anti-miR, anti-miR-10a or anti-miR-10b. The graph represents the values 
obtained from triplicate experiments (mean ± SD). H. Effect of RA treatment 
and miR-10a or -10b knockdown in the fraction of cells at the S-Phase of 
the cell cycle. The percentage of cells in S-phase was obtained analyzing 
the DNA content by cytometry after staining with Propidium Iodide. The 
effects of RA treatment in cells transfected with NC-anti-miR, anti-miR-10a 
or anti-miR-10b were compared with those observed in mock-transfected 
cells.  
 
A-G. Experimental reduction of miR-10a and -
10b levels impaired gene expression changes 
associated with RA-induced differentiation (A-
G). RT-qPCR analysis of the mRNA levels of 
NTRK2 (trkB, A), RET (B), GAP43 (C), ENO2 
(neuron-specific enolase, D), ID1 (E), ID2 (F) and 
ID3 (G). mRNA expression levels after RA 
treatment of SH-SY5Y cells transfected with 
anti-miR-10a , -10b or negative control (NC) 
anti-miR.  
A-C. Western blot analysis of the protein levels for ID2 (A), and the 
neuronal markers Neurofilament medium polypeptide (NFEM, B) and 
Tyroxine Hydroxylase (TH, C) after RA treatment of SH-SY5Y cells 
transfected with anti-miR-10a , -10b and negative control (NC) anti-miR. 
The filter was re-probed for beta-actin as loading control. 
A. Alternative splicing of tau protein exon 10 is altered by transfection 
of anti-miR-10a and -10b. RT-PCR was performed on RNA extracted 
from anti-miR-10a, -10b or negative control (NC) anti-miR transfected 
SH-SY5Y cells. tau Exon 10 flanking primers were used in RT-PCR 
reaction.  
B. Quantification of the percentage of exon 10 inclusion. The graph 
shows the value (mean ± SD) from 3 independent experiments.  
C. Schematic representation of the reporter genes used for the 
analysis of mRNA translation regulation.  
D. The effect of the alteration of miR-10a and -10b levels on the 
translation of the LCS-EDA luciferase reporters. Neuroblastoma cells 
were transfected in parallel reactions with either the LCS-EDA or the 
LCS-EDAmt Luciferase reporters and the corresponding pre-miR-10a, -
10b or NC-pre-miR, together with a promoterless Renilla luciferase 
reporter as internal control. After transfection, luciferase activities were 
determined and the ratio between the normalized activities of the LCS-
EDA and the LCS-EDAmt reporters is represented in the graph for the 
different transfection groups (mean ± SD of two triplicate experiments). 
A-F. Location of the putative miR-10a and -10b target sites in SFRS1 (A) and 
SFRS10 3’UTR (B). Unpaired bases are indicated in lowercase above and below the 
duplex. The predicted ∆G value for this structure is calculated by mFold analysis.  
C and D. Effects of miR-10a and -10b overexpression on the activity of SFRS1- (C) 
and SFRS10-3’UTR (D) Luciferase reporter constructs in HeLa cells. HeLa cells 
were co-transfected with pre-miR-10a and -10b or negative control pre-miR. Values 
(mean ± SD) are represented as relative light units obtained from three 
independent experiments performed in triplicate.  
E and F. Effects of miR-10a and -10b silencing on the activity of SFRS1- (E) and 
SFRS10-3’UTR (F) Luciferase reporter constructs in HeLa cells. HeLa cells were co-
transfected with anti-miR-10a and -10b or negative control anti-miR. Values (mean 
± SD) are represented as relative light units obtained from a experiment performed 
in triplicate.  
A-F. miR-10a/-10b knockdown leads to increased SFRS1 protein and mRNA levels in 
HeLa and SH-SY5Y cells. A and B. RT-qPCR analysis of miRNA-10a (A) and -10b (B) 
endogenous expression levels after transfection of HeLa cells with anti-miR-10a, 
and -10b as compared to negative control (NC) anti-miR. C. Western blot of SFRS1 
protein expression after anti-miR-10a, -10b and NC-anti-miR transfection of HeLa 
cells. D. RT-qPCR analysis of SFRS1 mRNA levels in the same conditions. The 
graph shows expression levels relative to that of cells transfected with NC-anti-miR 
(mean ± SD of a triplicate experiment). E. Western blot of SFRS1 protein expression 
after anti-miR-10a, -10b and negative control NC-anti-miR transfection of SH-SY5Y 
cells followed by RA treatment. F.  RT-qPCR analysis of SFRS1 mRNA levels in same 
conditions. The graph shows expression levels relative to that of RA untreated, NC-
anti-miR transfected cells (mean ± SD of a triplicate experiment) 
A-F miR-10a and -10b overexpression leads to 
a reduction of SFRS1 protein expression in 
HeLa and SH-SY5Y cells through a decrease of 
its mRNA levels. A and B. RT-qPCR analysis of 
miRNA-10a (A) and -10b (B) endogenous levels 
after transfection of HeLa cells with pre-miR-
10a, -10b as compared to negative control (NC) 
pre-miR.  
C Western blot analysis of SFRS1 protein 
expression in HeLa cells after transfection of 
negative control (NC) pre-miR, pre-miR-10a,or 
pre-miR-10b 
D. RT-qPCR analysis of SFRS1 mRNA 
expression in same conditions. The graph 
shows expression levels relative to that of cells 
transfected with NC-pre-miR (mean ± SD of a 
triplicate experiment). E. Western blot of SFRS1 
protein expression after pre-miR-10a, -10b and 
NC-pre-miR transfection of SH-SY5Y cells.. F. 
RT-qPCR analysis of SFRS1 mRNA levels in 
same conditions. The graph shows expression 
levels relative to that of RA untreated, NC-pre-
miR transfected cells (mean ± SD of a triplicate 
experiment)..  
